» Articles » PMID: 36905646

Long Noncoding RNA/circular RNA Regulates Competitive Endogenous RNA Networks in Rheumatoid Arthritis: Molecular Mechanisms and Traditional Chinese Medicine Therapeutic Significances

Overview
Journal Ann Med
Publisher Informa Healthcare
Specialty General Medicine
Date 2023 Mar 11
PMID 36905646
Authors
Affiliations
Soon will be listed here.
Abstract

Rheumatoid arthritis (RA) is a systemic and autoimmune disease that is mainly featured abnormal fibroblast-like synoviocyte (FLS) proliferation and inflammatory cell infiltration. Abnormal expression or function of long noncoding RNAs (lncRNAs) and circular RNAs (circRNAs) are closely related to human diseases, including RA. There has been increasing evidence showing that in the competitive endogenous RNA (ceRNA) networks, both lncRNA and circRNA are vital in the biological functions of cells. Nevertheless, the exact mechanism of ceRNA in RA remains to be investigated. Herein, we summarized the molecular potencies of lncRNA/circRNA-mediated ceRNA networks in RA, with emphasis on the phenotypic regulation of ceRNA in the progression of RA, including regulation of proliferation, invasion, inflammation and apoptosis, as well as the role of ceRNA in traditional Chinese medicine (TCM) in the treatment of RA. In addition, we also discussed the future direction and potential clinical value of ceRNA in the treatment of RA, which may provide potential reference value for clinical trials of TCM therapy for the treatment of RA.Key messagesLong noncoding RNA/circular RNA can work as the competitive endogenous RNA sponge and participate in the pathogenesis of rheumatoid arthritis.Traditional Chinese medicine and its agents have shown potential roles in the prevention and treatment of rheumatoid arthritis via competitive endogenous RNA.

Citing Articles

[LINC00837/miR-671-5p/SERPINE2 functional axis promotes pathological processes of fibroblast-like synovial cells in rheumatoid arthritis].

Cao Z, Wang Y, Wang M, Sun Y, Liu F Nan Fang Yi Ke Da Xue Xue Bao. 2025; 45(2):371-378.

PMID: 40031981 PMC: 11875867. DOI: 10.12122/j.issn.1673-4254.2025.02.18.


Unveiling new therapeutic horizons in rheumatoid arthritis: an In-depth exploration of circular RNAs derived from plasma exosomes.

Li G, Chen H, Shen J, Ding Y, Chen J, Zhang Y J Orthop Surg Res. 2025; 20(1):109.

PMID: 39881399 PMC: 11776339. DOI: 10.1186/s13018-025-05494-9.


LncRNA MIAT suppresses inflammation in LPS-induced J774A.1 macrophages by promoting autophagy through miR-30a-5p/SOCS1 axi.

Sun L, Yang K, Wang L, Wu S, Wen D, Wang J Sci Rep. 2024; 14(1):22608.

PMID: 39349964 PMC: 11442610. DOI: 10.1038/s41598-024-73607-1.


Anti-inflammatory properties and characterization of water extracts obtained from Callicarpa kwangtungensis Chun using in vitro and in vivo rat models.

Li J, Li L, Su S, Liao M, Gong Q, Liu M Sci Rep. 2024; 14(1):11047.

PMID: 38744989 PMC: 11094131. DOI: 10.1038/s41598-024-61892-9.


Roles of circRNAs in the progression of colorectal cancer: novel strategies for detection and therapy.

Mao J, Lu Y Cancer Gene Ther. 2024; 31(6):831-841.

PMID: 38337038 DOI: 10.1038/s41417-024-00739-x.


References
1.
Gerstein M, Kundaje A, Hariharan M, Landt S, Yan K, Cheng C . Architecture of the human regulatory network derived from ENCODE data. Nature. 2012; 489(7414):91-100. PMC: 4154057. DOI: 10.1038/nature11245. View

2.
Krek A, Grun D, Poy M, Wolf R, Rosenberg L, Epstein E . Combinatorial microRNA target predictions. Nat Genet. 2005; 37(5):495-500. DOI: 10.1038/ng1536. View

3.
Su Y, Liu Y, Ma C, Guan C, Ma X, Meng S . Mesenchymal stem cell-originated exosomal lncRNA HAND2-AS1 impairs rheumatoid arthritis fibroblast-like synoviocyte activation through miR-143-3p/TNFAIP3/NF-κB pathway. J Orthop Surg Res. 2021; 16(1):116. PMC: 7866436. DOI: 10.1186/s13018-021-02248-1. View

4.
Bartok B, Firestein G . Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunol Rev. 2010; 233(1):233-55. PMC: 2913689. DOI: 10.1111/j.0105-2896.2009.00859.x. View

5.
van der Woude D, van der Helm-van Mil A . Update on the epidemiology, risk factors, and disease outcomes of rheumatoid arthritis. Best Pract Res Clin Rheumatol. 2018; 32(2):174-187. DOI: 10.1016/j.berh.2018.10.005. View